Cancer Survivorship Specialists in MassachusettsPage 6

Shayna Sarosiek, MD

Senior Physician; Assistant Professor of Medicine, Harvard Medical School

Oncology

Franklin Huang, MD, PHD

Oncology

Ting Bao, M.D.

Director of the Zakim Center for Integrative Therapies and Healthy Living at the Dana-Farber Cancer Institute. She was a joint faculty member at Memoria

Oncology

Thomas Roberts, MD,MBA

Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

Oncology

David Jackman, M.D.

Director for Clinical Pathways and New Business Initiatives. His research interests include targeted therapies in lung cancer and mesothelioma, and canc; Senior Physician

Oncology

Laura Spring, M.D.

Assistant Professor of Medicine, Harvard Medical School

Oncology

Arielle Langer, MD, MPH

Instructor in Medicine, Harvard Medical School; Assistant Professor of Medicine, Brigham and Women's Hospital

Oncology

Christopher Lathan, M.D. M.S. M.P.H.

Chair at Dana Farber, and he serves as Dana-Farber’s Chief Clinical Access Officer. He is the Founding Director of Dana-Farber’s Cancer Care Access Program; Chief Medical Officer and Medical Director of Dana-Farber Cancer Institute’s Regional Campuses and currently serves as the chair for American Society of Cl

Oncology

Colin Weekes, M.D.

Director, Medical Oncology Research for Pancreatic Cancer, Tucker Gosnell Center for Gastrointestinal Cancers; Christopher D. Horner Endowed Chair in Pancreatic Cancer; Associate Professor of Medicine, Harvard Medical School

Oncology

Evan Chen, MD

Instructor in Medicine, Harvard Medical School

Oncology

Michael Serzan, MD

Instructor of Medicine at Harvard Medical School.; Chief Resident at Medstar Georgetown University Hospital. Dr. Serzan joined the Lank Center for Genitourinary Oncology in 2022 and has expertise in t

Oncology

Kenneth Kehl, MD

Director of Clinical Research; Assistant Professor of Medicine, Harvard Medical School

Oncology

David Ting, MD

Associate Professor of Medicine, Harvard Medical School; Associate Clinical Director for Innovation, Mass General Brigham Cancer Institute; Physician, Medicine-Hematology and Medical Oncology, Massachusetts General Hospital

Oncology

Aparna Parikh, M.D.

Oncology

Kerry Reynolds, MD

Assistant Professor of Medicine, Harvard Medical School; Clinical Director, Inpatient Oncology, Massachusetts General Hospital; Director, Severe Immunotherapy Complications Service, Mass General Brigham

Oncology

Adam Sperling, M.D.,PH.D.

Director of Basic and Correlative Science, Multiple Myeloma and Cell Therapies; Assistant Professor of Medicine, Harvard Medical School

Oncology

Jennifer Temel, MD

Professor of Medicine at Harvard Medical School, Clinical Director of Thoracic Oncology at Massachusetts General Hospital, Co-Director of the Cancer Outcomes Research and Education Program at Massachusetts General Hospital Cancer Center

Oncology

Jia Luo, MD

Assistant Professor of Medicine, Harvard Medical School; Chief Resident in Internal Medicine

Oncology

David Lovett, MD

Oncology

Oreofe Odejide, MD

Assistant Professor of Medicine, Harvard Medical School

Oncology